Best GLP-1 Weight Loss Programs in Delaware (2026)

Key factors include: medication type (compounded vs. brand-name), monthly cost and whether multi-month discounts exist, which specific medications are available (semaglutide, tirzepatide, or both), whether shipping is free, provider licensing in your state, and any additional services like coaching or metabolic testing.

Yes. Telehealth prescribing is legal across the U.S., subject to state law, though specific regulations vary. The providers listed here use licensed prescribers who are authorized to practice in Delaware. After a virtual consultation, your prescription is filled and shipped directly to your Delaware address.

Most programs require a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. You must be 18 or older. A licensed provider will evaluate your medical history during your telehealth consultation to determine eligibility.

Yes, several telehealth providers prescribe tirzepatide to Delaware residents. Tirzepatide is also the active ingredient in the separate FDA-approved brand-name products Mounjaro and Zepbound. Availability varies by provider — some offer only compounded tirzepatide, others prescribe brand-name versions, and a few do not carry tirzepatide at all. Check individual program details above for specific medication offerings.

Brand-name GLP-1s like Ozempic, Wegovy, and Zepbound are FDA-approved and manufactured by pharmaceutical companies. Compounded versions contain the same active ingredient but are prepared by compounding pharmacies, often at lower cost. The FDA permits compounding when brand-name drugs face shortages. Both types require a prescription from a licensed provider.